AU Patent

AU2013203779B2 — Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

Assigned to Ferring BV · Expires 2016-01-07 · 10y expired

What this patent protects

Abstract Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polys…

USPTO Abstract

Abstract Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid

Drugs covered by this patent

Patent Metadata

Patent number
AU2013203779B2
Jurisdiction
AU
Classification
—
Expires
2016-01-07
Drug substance claim
No
Drug product claim
No
Assignee
Ferring BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.